
### [MONDO:0019302](http://purl.obolibrary.org/obo/MONDO_0019302)
**Label:** mucopolysaccharidosis with skin involvement

**Subclasses:** [MONDO:0010674](http://purl.obolibrary.org/obo/MONDO_0010674) (mucopolysaccharidosis II), 

**Corr. equiv. classes:** [Orphanet:580](http://www.orpha.net/ORDO/Orphanet_580), [OMIM:309900](http://purl.obolibrary.org/obo/OMIM_309900), 

**Class expressions from DL-Learner:**

- [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) and [HP:0030799](http://purl.obolibrary.org/obo/HP_0030799) (Scaphocephaly) 75.00%
- [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 75.00%
- [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 75.00%
- [HP:0007703](http://purl.obolibrary.org/obo/HP_0007703) (Abnormality of retinal pigmentation) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0007367](http://purl.obolibrary.org/obo/HP_0007367) (Atrophy/Degeneration affecting the central nervous system) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0004329](http://purl.obolibrary.org/obo/HP_0004329) (Abnormality of the posterior segment of the globe) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0003510](http://purl.obolibrary.org/obo/HP_0003510) (Severe short stature) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0003508](http://purl.obolibrary.org/obo/HP_0003508) (Proportionate short stature) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0003502](http://purl.obolibrary.org/obo/HP_0003502) (Mild short stature) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0002187](http://purl.obolibrary.org/obo/HP_0002187) (Intellectual disability, profound) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0002180](http://purl.obolibrary.org/obo/HP_0002180) (Neurodegeneration) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0002159](http://purl.obolibrary.org/obo/HP_0002159) (Heparan sulfate excretion in urine) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0001098](http://purl.obolibrary.org/obo/HP_0001098) (Abnormality of the fundus) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%
- [HP:0000479](http://purl.obolibrary.org/obo/HP_0000479) (Abnormal retinal morphology) and [HP:0008301](http://purl.obolibrary.org/obo/HP_0008301) (Dermatan sulfate excretion in urine) 75.00%


